Clinical Trial Update: A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A prospective randomized study comparing target volume for limited-stage small cell lung cancer, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Carcinoma of Lung, Small Cell | Phase 2, Phase 3 | Status: UNKNOWN